MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience General and Administrative Expenses 2011-2026 | HBIO
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.7 M | 21.5 M | 22.8 M | 24.5 M | 24.3 M | 23.5 M | 22.8 M | 21.4 M | 18.6 M | 21 M | 19.8 M | 16.8 M | 19.9 M | 19.7 M | 18.1 M | 17.7 M | 15.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.5 M | 15.1 M | 20.3 M |
Quarterly General and Administrative Expenses Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.7 M | 4.18 M | 4.26 M | 5.18 M | - | 5.04 M | 5.69 M | 5.96 M | - | 5.81 M | 5.35 M | 6.33 M | - | 6.32 M | 5.98 M | 6.32 M | - | 5.46 M | 6.4 M | 6.33 M | - | 5.4 M | 5.67 M | 6.76 M | - | 6.6 M | 4.81 M | 5.8 M | - | 4.66 M | 5.26 M | 5.38 M | - | 4.32 M | 4.11 M | 4.79 M | - | 4.78 M | 5.24 M | 5.95 M | - | 5 M | 4.92 M | 4.83 M | - | 4.13 M | 4 M | 4 M | - | 4.65 M | 4.36 M | 4.22 M | - | 4.83 M | 4.9 M | 4.86 M | - | 4.56 M | 4.21 M | 4.36 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.76 M | 4 M | 5.15 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 67.34 | 8.58 % | $ 13.4 B | USA |
 |
Glaukos Corporation
GKOS
|
332 M | $ 125.0 | 2.72 % | $ 7.15 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.38 B | $ 422.06 | 0.77 % | $ 151 B | USA |
 |
Alcon
ALC
|
251 M | $ 66.81 | 0.35 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
625 M | $ 136.61 | 1.25 % | $ 3.37 B | USA |
 |
iRhythm Technologies
IRTC
|
493 M | $ 108.11 | 0.7 % | $ 3.46 B | USA |
 |
Repro Med Systems
KRMD
|
23.4 M | $ 3.93 | -5.07 % | $ 182 M | USA |
 |
LeMaitre Vascular
LMAT
|
42 M | $ 94.48 | 0.98 % | $ 2.14 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 178.82 | -0.04 % | $ 9.53 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
8.46 M | $ 1.84 | -6.12 % | $ 84.3 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
9.99 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
11.6 M | $ 0.42 | -4.31 % | $ 34.5 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
38.2 M | $ 8.72 | -12.27 % | $ 74 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 23.1 | 1.03 % | $ 3.88 B | USA |
 |
Haemonetics Corporation
HAE
|
442 M | $ 71.28 | 2.05 % | $ 3.36 B | USA |
 |
STERIS plc
STE
|
1.41 B | $ 212.35 | 0.05 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
30.2 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
85.8 M | $ 29.99 | 0.44 % | $ 1.49 B | USA |
 |
InfuSystem Holdings
INFU
|
57 M | $ 9.24 | 1.32 % | $ 191 M | USA |
 |
Teleflex Incorporated
TFX
|
720 M | $ 129.84 | -1.72 % | $ 5.79 B | USA |
 |
Utah Medical Products
UTMD
|
7.88 M | $ 67.65 | -0.5 % | $ 219 M | USA |
 |
Merit Medical Systems
MMSI
|
455 M | $ 64.48 | 2.28 % | $ 3.81 B | USA |
 |
West Pharmaceutical Services
WST
|
394 M | $ 314.5 | -0.89 % | $ 22.7 B | USA |
 |
Pulse Biosciences
PLSE
|
32 M | $ 25.33 | -5.98 % | $ 1.71 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.44 B | $ 10.0 | 1.21 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
12.8 M | $ 0.69 | 3.96 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 65.21 | -2.67 % | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
25.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
45.5 M | $ 26.64 | -1.66 % | $ 1.27 B | USA |
 |
Stereotaxis
STXS
|
17.8 M | $ 1.78 | -5.07 % | $ 162 M | USA |
 |
Baxter International
BAX
|
2.89 B | $ 19.38 | 0.16 % | $ 9.94 B | USA |
 |
ResMed
RMD
|
739 M | $ 196.04 | 0.89 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
311 M | $ 27.1 | -0.62 % | $ 1.29 B | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 11.94 | -0.75 % | $ 488 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 151.16 | 1.12 % | $ 43.5 B | USA |
 |
Nephros
NEPH
|
9 M | $ 3.42 | -4.74 % | $ 36.3 M | USA |
 |
OraSure Technologies
OSUR
|
47.7 M | $ 4.04 | -3.12 % | $ 297 M | USA |
 |
Repligen Corporation
RGEN
|
291 M | $ 122.31 | -3.35 % | $ 6.88 M | USA |